Endocrinology, Vol 125, 392-399, Copyright © 1989 by Endocrine Society

ARTICLES

Down-regulation of estrogen receptors by androgens in the ZR-75-1 human breast cancer cell line

R Poulin, J Simard, C Labrie, L Petitclerc, M Dumont, L Lagace and F Labrie
Medical Research Council Group in Molecular Endocrinology, Laval University Medical Center, Quebec, Canada.

Much clinical evidence indicates that androgens have beneficial effects in the treatment of breast cancer in women. Physiological concentrations of androgens strongly inhibit both basal and estrogen- induced cell proliferation in the human breast cancer cell line ZR-75-1 through their interaction with the androgen receptor. The present study shows that androgens strongly suppress estrogen receptor (ER) and progesterone receptor contents in this model, as measured by radioligand binding and anti-ER monoclonal antibodies. Similar inhibitory effects are observed on the levels of ER messenger RNA (mRNA) measured by ribonuclease protection assay. The androgenic effect is observed at subnanomolar concentrations of the nonaromatizable androgen 5 alpha-dihydrotestosterone, regardless of the presence of estrogens, and is competitively reversed by the antiandrogen hydroxyflutamide. Such data on ER expression provide an explanation for at least part of the antiestrogenic effects of androgens on breast cancer cell growth and moreover suggest that the specific inhibitory effects of androgen therapy could be additive to the standard treatment limited to blockade of estrogens by antiestrogens.

This article has been cited by other articles:

				S. N. Birrell, L. M. Butler, J. M. Harris, G. Buchanan, and W. D. Tilley Disruption of androgen receptor signaling by synthetic progestins may increase risk of developing breast cancer FASEB J, August 1, 2007; 21(10): 2285 - 2293. [Abstract] [Full Text] [PDF]

				F Labrie Future perspectives of selective estrogen receptor modulators used alone and in combination with DHEA. Endocr. Relat. Cancer, June 1, 2006; 13(2): 335 - 355. [Abstract] [Full Text] [PDF]

				R. S. Bhattacharyya, A. V. Krishnan, S. Swami, and D. Feldman Fulvestrant (ICI 182,780) down-regulates androgen receptor expression and diminishes androgenic responses in LNCaP human prostate cancer cells. Mol. Cancer Ther., June 1, 2006; 5(6): 1539 - 1549. [Abstract] [Full Text] [PDF]

				F Labrie, V Luu-The, A Belanger, S-X Lin, J Simard, G Pelletier, and C Labrie Is dehydroepiandrosterone a hormone? J. Endocrinol., November 1, 2005; 187(2): 169 - 196. [Abstract] [Full Text] [PDF]

				M. Lanzino, F. De Amicis, M. J. McPhaul, S. Marsico, M. L. Panno, and S. Ando Endogenous Coactivator ARA70 Interacts with Estrogen Receptor {alpha} (ER{alpha}) and Modulates the Functional ER{alpha}/Androgen Receptor Interplay in MCF-7 Cells J. Biol. Chem., May 27, 2005; 280(21): 20421 - 20430. [Abstract] [Full Text] [PDF]

				S. Durrer, K. Maerkel, M. Schlumpf, and W. Lichtensteiger Estrogen Target Gene Regulation and Coactivator Expression in Rat Uterus after Developmental Exposure to the Ultraviolet Filter 4-Methylbenzylidene Camphor Endocrinology, May 1, 2005; 146(5): 2130 - 2139. [Abstract] [Full Text] [PDF]

				R. F Fregosi Castrating the respiratory controller J. Physiol., December 1, 2004; 561(2): 353 - 353. [Full Text] [PDF]

				T. Saaresranta and O. Polo Sleep-disordered breathing and hormones Eur. Respir. J., July 1, 2003; 22(1): 161 - 172. [Abstract] [Full Text] [PDF]

				F. Labrie, V. Luu-The, C. Labrie, A. Belanger, J. Simard, S.-X. Lin, and G. Pelletier Endocrine and Intracrine Sources of Androgens in Women: Inhibition of Breast Cancer and Other Roles of Androgens and Their Precursor Dehydroepiandrosterone Endocr. Rev., April 1, 2003; 24(2): 152 - 182. [Abstract] [Full Text] [PDF]

				T. Saaresranta and O. Polo Hormones and Breathing Chest, December 1, 2002; 122(6): 2165 - 2182. [Abstract] [Full Text] [PDF]

				J.-L. Carsol, S. Gingras, and J. Simard Synergistic Action of Prolactin (PRL) and Androgen on PRL-Inducible Protein Gene Expression in Human Breast Cancer Cells: A Unique Model for Functional Cooperation between Signal Transducer and Activator of Transcription-5 and Androgen Receptor Mol. Endocrinol., July 1, 2002; 16(7): 1696 - 1710. [Abstract] [Full Text] [PDF]

				J. Lapointe and C. Labrie Role of the Cyclin-Dependent Kinase Inhibitor p27Kip1 in Androgen-Induced Inhibition of CAMA-1 Breast Cancer Cell Proliferation Endocrinology, October 1, 2001; 142(10): 4331 - 4338. [Abstract] [Full Text] [PDF]

				T. SAARESRANTA, K. IRJALA, P. POLO-KANTOLA, H. HELENIUS, and O. POLO Prolonged Endocrine Responses to Medroxyprogesterone in Postmenopausal Women With Respiratory Insufficiency Obstet. Gynecol., August 1, 2000; 96(2): 243 - 249. [Abstract] [Full Text] [PDF]

				N. Alos, A.-M. Moisan, L. Ward, M. Desrochers, L. Legault, G. Leboeuf, G. Van Vliet, and J. Simard A Novel A10E Homozygous Mutation in the HSD3B2 Gene Causing Severe Salt-Wasting 3{beta}-Hydroxysteroid Dehydrogenase Deficiency in 46,XX and 46,XY French-Canadians: Evaluation of Gonadal Function after Puberty J. Clin. Endocrinol. Metab., May 1, 2000; 85(5): 1968 - 1974. [Abstract] [Full Text]

				J. Lapointe and C. Labrie Identification and Cloning of a Novel Androgen-Responsive Gene, Uridine Diphosphoglucose Dehydrogenase, in Human Breast Cancer Cells Endocrinology, October 1, 1999; 140(10): 4486 - 4493. [Abstract] [Full Text]

				J. Lapointe, A. Fournier, V. Richard, and C. Labrie Androgens Down-Regulate bcl-2 Protooncogene Expression in ZR-75-1 Human Breast Cancer Cells Endocrinology, January 1, 1999; 140(1): 416 - 421. [Abstract] [Full Text]

				M. Lessard, C. Zhao, S. M. Singh, and R. Poulin Hormonal and Feedback Regulation of Putrescine and Spermidine Transport in Human Breast Cancer Cells J. Biol. Chem., January 27, 1995; 270(4): 1685 - 1694. [Abstract] [Full Text] [PDF]